Weed (BUDZ) Tax Provisions (2024 - 2025)
Weed's (BUDZ) quarterly Tax Provisions came in at $1.4 million in Q4 2025, up 4157900.0% quarter-over-quarter from $33.0 in Q3 2025.
Weed (BUDZ) Tax Provisions (2024 - 2025) Analysis & Trends
Weed's Tax Provisions history runs 2 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- On a quarterly basis, Tax Provisions changed N/A year-over-year to $1.4 million in Q4 2025; TTM through Mar 2026 was $1.4 million, a 343803.01% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 343803.01% from the prior year.
- Tax Provisions rose to $1.4 million in Q4 2025 per BUDZ's latest filing, from $33.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $1.4 million in Q4 2025 and bottomed at $33.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.37 Mn |
| Sep 30, 2025 | 33.00 |
| Jun 30, 2024 | 399.00 |